Lonza Signs Manufacturing Deal with U.S. Biopharma Firm

06:49 AM | November 25, 2009 | Deepti Ramesh

Lonza says it has entered into an agreement with biopharmaceutical company Micromet (Bethesda, MD) for the process development and manufacture of Micromet’s blinatumomab, a BiTE antibody for the...